Log In
Print
BCIQ
Print
Print this Print this
 

RG7667

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionNME against cytomegalovirus (CMV)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard Indication Infectious (unspecified)
Indication DetailsPrevent cytomegalovirus (CMV) disease in kidney transplant recipients; Treat infectious diseases
Regulatory Designation

Partner

Genentech Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today